Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178679
Status:
RECRUITING
Last Update Posted:
2024-01-18
First Post:
2023-12-07
Brief Title:
Safety and Efficacy of ST-100 Vezocolmitide Ophthalmic Solution 60 μgml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease DED
Sponsor:
ORA Inc
Organization:
ORA Inc
Study Overview
Official Title:
A Phase 3 Multi-Center Randomized Double Masked Vehicle Controlled Study to Assess the Safety and Efficacy of ST-100 Vezocolmitide Ophthalmic Solution 60 μgml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease DED
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase 3 Multi-Center Randomized Double Masked Vehicle Controlled Study to Assess the Safety and Efficacy of ST-100 vezocolmitide Ophthalmic Solution 60 μgml Ophthalmic Solution in Subjects Diagnosed with Dry Eye Disease DED
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None